Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

neon healthcare ltd - buserelin acetate - solution for injection - 1mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

neon healthcare ltd - buserelin acetate - spray - 100microgram/1dose

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - buserelin acetate -

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin - solution for injection - 1 mg/ml - active: buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin excipient: benzyl alcohol monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection - for the treatment of endometriosis not primarily requiring surgical treatment. pituitary desensitisation in preparation for ovulation induction regimens using gonadotrophins.

Kanāda - angļu - Health Canada

cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 100mcg - buserelin (buserelin acetate) 100mcg - antineoplastic agents

Kanāda - angļu - Health Canada

cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 1mg - buserelin (buserelin acetate) 1mg - antineoplastic agents

Īrija - angļu - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited - buserelin - implant - 6.3 milligram

Īrija - angļu - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - buserelin - implant - 6.3 milligram